Physician profile
Edward Ellis
NPI 1750348199
$33,122.06
in general payments reported to CMS, 2019-2025
7 companies · $9,416 in 2025
The $9,416 reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,137 · 2020: $369 · 2021: $6,928 · 2022: $9,741 · 2024: $1,531 · 2025: $9,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,890 · Food and Beverage: $1,040 · Travel and Lodging: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,890.00 |
| Food and Beverage | $1,040.27 |
| Travel and Lodging | $1,016.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $19,902.90 | 2021-2025 | Trumatch, Matrixcombo |
| Synthes Gmbh | $11,927.12 | 2019-2022 | |
| Kls-Martin L.P. | $482.11 | 2019-2025 | |
| Axogen | $375.93 | 2020-2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Depuy Synthes Sales INC. | $283.31 | 2019-2025 | Trumatch, Matrixorthognathic |
| Stryker Corporation | $116.60 | 2022 | |
| Synthes USA Products LLC | $34.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.